Annovis Bio, Inc. (ANVS)

USD 1.61

(2.55%)

Revenue Summary of Annovis Bio, Inc.

  • Annovis Bio, Inc.'s latest annual revenue in 2023 was - USD , down 0.0% from previous year.
  • Annovis Bio, Inc.'s latest quarterly revenue in 2024 Q1 was - USD , down 0.0% from previous quarter.
  • Annovis Bio, Inc. reported a annual revenue of - USD in annual revenue 2022, down 0.0% from previous year.
  • Annovis Bio, Inc. reported a annual revenue of - USD in annual revenue 2021, down 0.0% from previous year.
  • Annovis Bio, Inc. reported a quarterly revenue of - USD for 2024 Q1, down 0.0% from previous quarter.
  • Annovis Bio, Inc. reported a quarterly revenue of - USD for 2023 Q2, down 0.0% from previous quarter.

Annual Revenue Chart of Annovis Bio, Inc. (2023 - 2017)

Historical Annual Revenue of Annovis Bio, Inc. (2023 - 2017)

Year Revenue Revenue Growth
2023 - USD 0.0%
2022 - USD 0.0%
2021 - USD 0.0%
2020 - USD 0.0%
2019 - USD 0.0%
2018 - USD 0.0%
2017 - USD 0.0%

Peer Revenue Comparison of Annovis Bio, Inc.

Name Revenue Revenue Difference
ADC Therapeutics SA 69.55 Million USD 100.0%
Alto Neuroscience, Inc. - USD NaN%
Biohaven Pharmaceutical Holding Company Ltd. - USD NaN%
Ginkgo Bioworks Holdings, Inc. 251.45 Million USD 100.0%
Nuvation Bio Inc. - USD NaN%
Nuvation Bio Inc. - USD NaN%
Arcus Biosciences, Inc. 117 Million USD 100.0%
Zymeworks Inc. 76.01 Million USD 100.0%